Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Trials. 2023 Feb 28;24(1):149. doi: 10.1186/s13063-023-07183-6.
Research into life-threatening illnesses which require emergency hospitalisation is essential. This group of patients is unique in that they are experiencing an unfolding emergency when they are approached, enrolled, and followed up in a research study. We aimed to synthesise qualitative data from trial participants and surrogate decision-makers to deepen our understanding and inform the design and conduct of future clinical trials for life-threatening illnesses.
We conducted a critical interpretive synthesis of qualitative data from trial participants and surrogate decision-makers related to the experience of participating in a clinical research study when suffering from a life-threatening illness. A scoping review informed a systematic review of published data. We searched research databases and reviewed papers for inclusion. Primary data and interpretations of data were extracted from each paper. Data were analysed using reciprocal translational analysis, refutational synthesis, and lines of argument synthesis to develop a synthetic construct.
Twenty-two papers were included. Most individuals had no previous knowledge or experience with clinical research. Individuals making decisions were directly experiencing or witness to an unfolding emergency which came with a myriad of physical and psychological symptoms. It was difficult to differentiate clinical research and routine care, and understanding of core concepts around research, particularly randomisation and equipoise, was limited. We found that this led to an underestimation of risk, an overestimation of benefit, and an expectation of being allocated to the intervention arm. The decision-making process was heavily influenced by trust in the research team. Individuals suggested that abbreviated information, presented in different ways and continuously throughout the research process, would have increased knowledge and satisfaction with the research process.
Individuals suffering from a life-threatening illness who are being invited to participate in clinical research need to be managed in a way that adapts to the severity of their illness and there is a need to tailor research processes, including informed consent, accordingly. We provide suggestions for further research and implementation work around research participation for individuals suffering from a life-threatening illness.
PROSPERO CRD42020207296.
对危及生命的疾病进行研究至关重要,这些疾病需要紧急住院治疗。这组患者的独特之处在于,当他们在研究中被接触、登记和随访时,他们正在经历一场正在展开的紧急情况。我们旨在综合来自试验参与者和替代决策人的定性数据,以加深我们的理解,并为危及生命的疾病的未来临床试验的设计和实施提供信息。
我们对来自试验参与者和替代决策人关于在患有危及生命的疾病时参与临床研究的经验的定性数据进行了批判性解释性综合。范围综述为已发表数据的系统综述提供了信息。我们搜索了研究数据库并审查了纳入的论文。从每篇论文中提取主要数据和对数据的解释。使用相互翻译分析、反驳性综合和论证线综合来分析数据,以开发综合结构。
共纳入 22 篇论文。大多数人以前没有临床研究方面的知识或经验。做出决策的人直接经历或目睹了一场正在展开的紧急情况,伴随着许多身体和心理症状。很难区分临床研究和常规护理,对研究的核心概念,特别是随机化和均衡,的理解有限。我们发现这导致了对风险的低估、对益处的高估以及对被分配到干预组的期望。决策过程受到对研究团队信任的极大影响。个人建议,通过在研究过程中以不同的方式和不断提供简短信息,会增加对研究过程的了解和满意度。
正在邀请参与临床研究的患有危及生命的疾病的个人需要以适应其疾病严重程度的方式进行管理,并且需要相应地调整研究过程,包括知情同意。我们为围绕患有危及生命的疾病的个人的研究参与进行进一步研究和实施工作提供了建议。
PROSPERO CRD42020207296。